Mar 16, 2020
The Global Shingles Vaccine Market is expected to grow by USD 1.08 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period
Nov 28, 2019
The global varicella live vaccine market was valued at $2,714 million in 2018, and is expected to reach $4,222 million by 2026, registering a CAGR of 5.7% from 2019 to 2026
Aug 26, 2019
NanoViricides, Inc. Has Filed its Annual Report, Company Advancing Rapidly Towards First IND
Apr 16, 2019
NanoViricides Submits Pre-IND Briefing Documents to the US FDA
Mar 26, 2019
NanoViricides has Requested a Pre-IND Meeting with the US FDA
Feb 27, 2019
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
Feb 26, 2019
NanoViricides Reaches an Agreement on Terms of License for Shingles Virus Drug Development
Feb 19, 2019
NanoViricides Files Quarterly Report for Period Ending December 31, 2018 - HerpeCide Drug Candidate Progressing in IND-Enabling Studies Towards Clinical Trials
Feb 11, 2019
NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm
Feb 04, 2019
NanoViricides Has Initiated IND-Enabling Safety/Toxicology Studies for Its First Drug Candidate Moving towards Human Clinical Trials
Jan 14, 2019
Saol Therapeutics Announces CDC has Updated Information Related to Use and Availability of VARIZIG® (Varicella Zoster Immune Globulin [Human])
Nov 26, 2018
NanoViricides Files Quarterly Report for Period Ending September 30, 2018
Nov 05, 2018
Curevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate
Oct 15, 2018
On the Heels of Positive In-Vivo Data for Shingles of the Eye Drug Candidate, Global Health Solutions Rebrands as Turn Therapeutics
Oct 15, 2018
NanoViricides Has Filed its Annual Report, Company Reports Strong Progress in Advancement of HerpeCide Program
Sep 28, 2018
NanoViricides Inc. to Present at the MicroCap Conference in New York City on October 1
Sep 05, 2018
NanoViricides Inc. to Present at 20th Annual Rodman & Renshaw Conference in NYC on Sept 6th
Sep 05, 2018
Over 50? You Need This Vaccine to Protect Your Vision
Aug 07, 2018
NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study
Aug 01, 2018
Family Physicians: Shingles Vaccine for Adults 50+, Don't Delay